Login Register Cart 0
Generic placeholder image

Recent Advances in Inflammation & Allergy Drug Discovery

Editor-in-Chief

ISSN (Print): 2772-2708
ISSN (Online): 2772-2716

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

Hand, Foot, and Mouth Disease: A Narrative Review

Author(s): Alexander K. C. Leung*, Joseph M. Lam, Benjamin Barankin, Kin Fon Leong and Kam Lun Hon

Volume 16, Issue 2, 2022

Published on: 07 November, 2022

Page: [77 - 95] Pages: 19

DOI: 10.2174/1570180820666221024095837

Price: $65

Abstract

Background: Hand, foot, and mouth disease is a common viral disease in childhood. Because the disease has the potential to reach epidemic levels and mortality is high in some countries, early recognition of this disease is of paramount importance.

Objective: This purpose of this article is to familiarize pediatricians with the clinical manifestations and management of hand, foot, and mouth disease.

Methods: A search was conducted in February 2022 in PubMed Clinical Queries using the key term "hand, foot, and mouth disease". The search strategy included all clinical trials, observational studies, and reviews published within the past 10 years. Only papers published in English were included in this review.

Results: Hand, foot, and mouth disease is characterized by a painful oral enanthem and asymptomatic exanthem on the palms and soles. Children younger than 5 years are most commonly affected. Hand, foot, and mouth disease caused by enterovirus A71 is more severe and has a higher rate of complications than that attributed to other viruses such as coxsackievirus A16. Circulatory failure secondary to myocardial impairment and neurogenic pulmonary edema secondary to brainstem damage are the main causes of death. Fortunately, the disease is usually benign and resolves in 7 to10 days without sequelae. Given the self-limited nature of most cases, treatment is mainly symptomatic and supportive. Intravenous immunoglobulin should be considered for the treatment of severe/complicated hand, foot, and mouth disease and has been recommended by several national and international guideline committees. Currently, there are no specific antiviral agents approved for the treatment of the disease. Drugs such as ribavirin, suramin, mulberroside C, aminothiazole analogs, and sertraline have emerged as potential candidates for the treatment of hand, foot, and mouth disease. Vaccination of susceptible individuals in high-risk areas and good personal hygiene are important preventative measures to combat the disease.

Conclusion: Familiarity of the disease including its atypical manifestations is crucial so that a correct diagnosis can be made, and appropriate treatment initiated. A timely diagnosis can help avoid contact with the affected individual and decrease the risk of an outbreak.

« Previous
Graphical Abstract

[1]
Cherry JD, Jahn CL. Hand, foot, and mouth syndrome. Report of six cases due to coxsackie virus, group A, type 16. Pediatrics 1966; 37(4): 637-43.
[http://dx.doi.org/10.1542/peds.37.4.637] [PMID: 5930026]
[2]
Cox B, Levent F. Hand, foot, and mouth disease. JAMA 2018; 320(23): 2492.
[http://dx.doi.org/10.1001/jama.2018.17288] [PMID: 30561482]
[3]
Toida M, Watanabe F, Goto K, Shibata T. Usefulness of low-level laser for control of painful stomatitis in patients with hand-foot-and-mouth disease. J Clin Laser Med Surg 2003; 21(6): 363-7.
[http://dx.doi.org/10.1089/104454703322650176] [PMID: 14709221]
[4]
Frydenberg A, Starr M. Hand, foot and mouth disease. Aust Fam Physician 2003; 32(8): 594-5.
[PMID: 12973865]
[5]
Guerra AM, Orille E, Waseem M. Hand foot and mouth disease 2021.
[6]
Lalani S, Gew LT, Poh CL. Antiviral peptides against Enterovirus A71 causing hand, foot and mouth disease. Peptides 2021; 136: 170443.
[http://dx.doi.org/10.1016/j.peptides.2020.170443] [PMID: 33171280]
[7]
Tang J, Zhang Z, Zhang Z, et al. Two cases of hand, foot and mouth disease caused by enterovirus A71 after vaccination. Int J Infect Dis 2021; 108: 190-7.
[http://dx.doi.org/10.1016/j.ijid.2021.03.039] [PMID: 33737136]
[8]
Bian L, Gao F, Mao Q, et al. Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems. Expert Rev Anti Infect Ther 2019; 17(4): 233-42.
[http://dx.doi.org/10.1080/14787210.2019.1585242] [PMID: 30793637]
[9]
Leung AKC. Hand-foot-and mouth disease The Encyclopedia of Molecular Mechanism of Disease. Berlin: Springer-Verlag 2009; p. 771.
[10]
Leung AKC. Hand, foot, and mouth disease Common Problems in Ambulatory Pediatrics: Specific Clinical Problems. New York: Nova Science Publishers, Inc. 2011; Vol. 1: pp. 297-301.
[11]
Liu H, Zhang M, Feng C, et al. Characterization of Coxsackievirus A6 strains isolated from children with hand, foot, and mouth Disease. Front Cell Infect Microbiol 2021; 11: 700191.
[http://dx.doi.org/10.3389/fcimb.2021.700191] [PMID: 34490141]
[12]
Romero JR. Hand, foot, and mouth disease and herpangina.UpToDate.
[13]
Zhang M, Xu D, Feng C, et al. Isolation and characterization of a novel clade of coxsackievirus B2 associated with hand, foot, and mouth disease in Southwest China. J Med Virol 2022; 94(6): 2598-606. Online ahead of print
[http://dx.doi.org/10.1002/jmv.27657] [PMID: 35149996]
[14]
Zhang M, Guo W, Xu D, et al. Molecular characterization of echovirus 9 strains isolated from hand-foot-and-mouth disease in Kunming, Yunnan Province, China. Sci Rep 2022; 12(1): 2293.
[http://dx.doi.org/10.1038/s41598-022-06309-1] [PMID: 35145190]
[15]
Zhang J, Xu D, Liu H, et al. Characterization of coxsackievirus A10 strains isolated from children with hand, foot, and mouth disease. J Med Virol 2022; 94(2): 601-9.
[http://dx.doi.org/10.1002/jmv.27268] [PMID: 34387895]
[16]
Cai K, Wang Y, Guo Z, et al. Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China. BMC Infect Dis 2019; 19(1): 285.
[http://dx.doi.org/10.1186/s12879-019-3878-6] [PMID: 30917800]
[17]
Esposito S, Principi N. Hand, foot and mouth disease: Current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur J Clin Microbiol Infect Dis 2018; 37(3): 391-8.
[http://dx.doi.org/10.1007/s10096-018-3206-x] [PMID: 29411190]
[18]
Fang CY, Liu CC. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease. Expert Rev Vaccines 2018; 17(9): 819-31.
[http://dx.doi.org/10.1080/14760584.2018.1510326] [PMID: 30095317]
[19]
Pintor E, Herreros B, Gargantilla P, Gutiérrez MJ. Hand, foot and mouth disease in an adult. Infection 2018; 46(3): 437-8.
[http://dx.doi.org/10.1007/s15010-018-1118-4] [PMID: 29372548]
[20]
Zhou Y, Van Tan L, Luo K, et al. Genetic variation of multiple serotypes of enteroviruses associated with hand, foot and mouth disease in Southern China. Virol Sin 2021; 36(1): 61-74.
[http://dx.doi.org/10.1007/s12250-020-00266-7] [PMID: 32725479]
[21]
Österback R, Vuorinen T, Linna M, Susi P, Hyypiä T, Waris M. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg Infect Dis 2009; 15(9): 1485-8.
[http://dx.doi.org/10.3201/eid1509.090438] [PMID: 19788821]
[22]
Wang SM, Liu CC. Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect Ther 2009; 7(6): 735-42.
[http://dx.doi.org/10.1586/eri.09.45] [PMID: 19681701]
[23]
Chea S, Cheng Y, Chokephaibulkit K, et al. Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia. Emerg Infect Dis 2015; 21(1): e140992.
[http://dx.doi.org/10.3201/eid2101.140992] [PMID: 25531166]
[24]
Tan YW, Chu JJH. Protecting the most vulnerable from hand, foot, and mouth disease. Lancet Infect Dis 2021; 21(3): 308-9.
[http://dx.doi.org/10.1016/S1473-3099(20)30452-7] [PMID: 33031751]
[25]
Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008–12: an epidemiological study. Lancet Infect Dis 2014; 14(4): 308-18.
[http://dx.doi.org/10.1016/S1473-3099(13)70342-6] [PMID: 24485991]
[26]
Chen W, Yang Z, Lian L, Xu L. Case report. Medicine (Baltimore) 2017; 96(42): e8307.
[http://dx.doi.org/10.1097/MD.0000000000008307] [PMID: 29049234]
[27]
Klein M, Chong P. Is a multivalent hand, foot, and mouth disease vaccine feasible? Hum Vaccin Immunother 2015; 11(11): 2688-704.
[http://dx.doi.org/10.1080/21645515.2015.1049780] [PMID: 26009802]
[28]
Xu S, Li H, Qiao P, et al. Neonatal hand, foot, and mouth disease due to coxsackievirus A6 in Shanghai. BMC Pediatr 2020; 20(1): 364.
[http://dx.doi.org/10.1186/s12887-020-02262-y] [PMID: 32741368]
[29]
Repass GL, Palmer WC, Stancampiano FF. Hand, foot, and mouth disease: Identifying and managing an acute viral syndrome. Cleve Clin J Med 2014; 81(9): 537-43.
[http://dx.doi.org/10.3949/ccjm.81a.13132] [PMID: 25183845]
[30]
Saguil A, Kane SF, Lauters R, Mercado MG. Hand-foot-and-mouth disease: Rapid evidence review. Am Fam Physician 2019; 100(7): 408-14.
[PMID: 31573162]
[31]
Sutton-Hayes S, Weisse ME, Wilson NW, Ogershok PR. A recurrent presentation of hand, foot, and mouth disease. Clin Pediatr (Phila) 2006; 45(4): 373-6.
[http://dx.doi.org/10.1177/000992280604500412] [PMID: 16703163]
[32]
Coates SJ, Davis MDP, Andersen LK. Temperature and humidity affect the incidence of hand, foot, and mouth disease: a systematic review of the literature - a report from the International Society of Dermatology Climate Change Committee. Int J Dermatol 2019; 58(4): 388-99.
[http://dx.doi.org/10.1111/ijd.14188] [PMID: 30187452]
[33]
Abdul Wahid NA, Suhaila J, Rahman HA. Effect of climate factors on the incidence of hand, foot, and mouth disease in Malaysia: A generalized additive mixed model. Infect Dis Model 2021; 6: 997-1008.
[http://dx.doi.org/10.1016/j.idm.2021.08.003] [PMID: 34466760]
[34]
Cheng Q, Bai L, Zhang Y, et al. Ambient temperature, humidity and hand, foot, and mouth disease: A systematic review and meta-analysis. Sci Total Environ 2018; 625: 828-36.
[http://dx.doi.org/10.1016/j.scitotenv.2018.01.006] [PMID: 29306826]
[35]
Li C, Zhu Y, She K, et al. Modified effects of air pollutants on the relationship between temperature variability and hand, foot, and mouth disease in Zibo City, China. Environ Sci Pollut Res Int 2022; 29(29): 44573-81.
[http://dx.doi.org/10.1007/s11356-022-18817-8] [PMID: 35133585]
[36]
Wang J, Li S. Nonlinear effect of temperature on hand, foot, and mouth disease in Lanzhou, China. Medicine (Baltimore) 2020; 99(45): e23007.
[http://dx.doi.org/10.1097/MD.0000000000023007] [PMID: 33157945]
[37]
Omaña-Cepeda C, Martínez-Valverde A. del Mar Sabater- Recolons M, Jané-Salas E, Marí-Roig A, López-López J. A literature review and case report of hand, foot and mouth disease in an immunocompetent adult. BMC Res Notes 2016; 9(1): 165.
[http://dx.doi.org/10.1186/s13104-016-1973-y] [PMID: 26975350]
[38]
Du Z, Yang B, Jalaludin B, et al. Association of neighborhood greenness with severity of hand, foot, and mouth disease. BMC Public Health 2022; 22(1): 38.
[http://dx.doi.org/10.1186/s12889-021-12444-7] [PMID: 34991526]
[39]
Herrero LJ, Lee CSM, Hurrelbrink RJ, Chua BH, Chua KB, McMinn PC. Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997?2000. Arch Virol 2003; 148(7): 1369-85.
[http://dx.doi.org/10.1007/s00705-003-0100-2] [PMID: 12827466]
[40]
Shah VA, Chong CY, Chan KP, Ng W, Ling AE. Clinical characteristics of an outbreak of hand, foot and mouth disease in Singapore. Ann Acad Med Singap 2003; 32(3): 381-7.
[PMID: 12854382]
[41]
Li XW, Ni X, Qian SY, et al. Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition). World J Pediatr 2018; 14(5): 437-47.
[http://dx.doi.org/10.1007/s12519-018-0189-8] [PMID: 30280313]
[42]
Modlin JF. Enterovirus déjà vu. N Engl J Med 2007; 356(12): 1204-5.
[http://dx.doi.org/10.1056/NEJMp078016] [PMID: 17377157]
[43]
McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol 2001; 75(16): 7732-8.
[http://dx.doi.org/10.1128/JVI.75.16.7732-7738.2001] [PMID: 11462047]
[44]
Adler JL, Mostow SR, Mellin H, Janney JH, Joseph JM. Epidemiologic investigation of hand, foot, and mouth disease. Infection caused by coxsackievirus A 16 in Baltimore, June through September 1968. Am J Dis Child 1970; 120(4): 309-14.
[http://dx.doi.org/10.1001/archpedi.1970.02100090083005] [PMID: 5493828]
[45]
Alsop J, Flewett TH, Foster JR. “Hand-Foot-and-Mouth Disease” in Birmingham in 1959. BMJ 1960; 2(5214): 1708-11.
[http://dx.doi.org/10.1136/bmj.2.5214.1708] [PMID: 13682692]
[46]
Chatproedprai S, Theanboonlers A, Korkong S, Thongmee C, Wananukul S, Poovorawan Y. Clinical and molecular characterization of hand-foot-and-mouth disease in Thailand, 2008-2009. Jpn J Infect Dis 2010; 63(4): 229-33.
[http://dx.doi.org/10.7883/yoken.63.229] [PMID: 20657060]
[47]
Froeschle JE, Nahmias AJ, Feorino PM, McCord G, Naib Z. Hand, foot, and mouth disease (Coxsackievirus A16) in Atlanta. Arch Pediatr Adolesc Med 1967; 114(3): 278-83.
[http://dx.doi.org/10.1001/archpedi.1967.02090240092006] [PMID: 6038264]
[48]
Richardson HB Jr, Leibovitz A. Hand, foot, and mouth disease in children. J Pediatr 1965; 67(1): 6-12.
[http://dx.doi.org/10.1016/S0022-3476(65)80297-9] [PMID: 14301560]
[49]
Neri I, Sechi A, Leuzzi M, Chessa MA, Virdi A, Patrizi A. Hand-foot-mouth disease mimicking diaper dermatitis. Arch Dis Child 2018; 103(9): 846.
[http://dx.doi.org/10.1136/archdischild-2017-313874] [PMID: 28982663]
[50]
Ventarola D, Bordone L, Silverberg N. Update on hand-foot-and-mouth disease. Clin Dermatol 2015; 33(3): 340-6.
[http://dx.doi.org/10.1016/j.clindermatol.2014.12.011] [PMID: 25889136]
[51]
Buttery VW, Kenyon C, Grunewald S, Oberste MS, Nix WA. Atypical presentations of hand, foot, and mouth disease caused by coxsackievirus A6--Minnesota, 2014. MMWR Morb Mortal Wkly Rep 2015; 64(30): 805.
[http://dx.doi.org/10.15585/mmwr.mm6429a8] [PMID: 26225481]
[52]
Neri I, Chessa MA, Virdi A, Patrizi Prof A. Hand, foot and mouth disease: an overview of clinical features in adult patients. J Eur Acad Dermatol Venereol 2017; 31(5): e257-9.
[http://dx.doi.org/10.1111/jdv.14043] [PMID: 27859744]
[53]
Justino MCA, da S Mesquita D, Souza MF, et al. Atypical hand-foot-mouth disease in Belém, Amazon region, northern Brazil, with detection of coxsackievirus A6. J Clin Virol 2020; 126: 104307.
[http://dx.doi.org/10.1016/j.jcv.2020.104307] [PMID: 32302950]
[54]
Chang LY, Lee CY, Kao CL, et al. Hand, foot and mouth disease complicated with central nervous system involvement in Taiwan in 1980-1981. J Formos Med Assoc 2007; 106(2): 173-6.
[http://dx.doi.org/10.1016/S0929-6646(09)60236-9] [PMID: 17339164]
[55]
Chong C-Y, Chan K-P, Shah VA, et al. Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta Paediatr 2003; 92(10): 1163-9.
[http://dx.doi.org/10.1111/j.1651-2227.2003.tb02478.x] [PMID: 14632332]
[56]
Horsten H, Kemp M, Fischer T, Lindahl K, Bygum A. Atypical hand, foot, and mouth disease caused by coxsackievirus A6 in Denmark: A diagnostic mimicker. Acta Derm Venereol 2018; 98(3): 350-4.
[http://dx.doi.org/10.2340/00015555-2853] [PMID: 29182793]
[57]
Chatproedprai S, Tempark T, Wanlapakorn N, Puenpa J, Wananukul S, Poovorawan Y. Unusual skin manifestation of hand, foot and mouth disease associated with coxsackievirus A6: cases report. Springerplus 2015; 4(1): 362.
[http://dx.doi.org/10.1186/s40064-015-1143-z] [PMID: 26203408]
[58]
Chong JH, Aan MKJ. An atypical dermatologic presentation of a child with hand, foot and mouth disease caused by coxsackievirus A6. Pediatr Infect Dis J 2014; 33(8): 889.
[http://dx.doi.org/10.1097/INF.0000000000000310] [PMID: 25222313]
[59]
Farah M, El Chaer F, El Khoury J, El Zakhem A. Erythema multiforme‐like hand, foot, and mouth disease in an immunocompetent adult: a case report. Int J Dermatol 2020; 59(4): 487-9.
[http://dx.doi.org/10.1111/ijd.14713] [PMID: 31742678]
[60]
Harris PNA, Wang AD, Yin M, Lee CK, Archuleta S. Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults. Lancet Infect Dis 2014; 14(11): 1043.
[http://dx.doi.org/10.1016/S1473-3099(14)70976-4] [PMID: 25444404]
[61]
Hoffmann AJ, Latrous M, Lam JM. Atypical hand-foot-and-mouth disease. CMAJ 2020; 192(3): E69.
[http://dx.doi.org/10.1503/cmaj.191100] [PMID: 31959658]
[62]
Huang H, Deng L, Jia L, Zhu R. A clinical scoring system for pediatric hand-foot-mouth disease. BMC Infect Dis 2021; 21(1): 722.
[http://dx.doi.org/10.1186/s12879-021-06424-w] [PMID: 34332544]
[63]
Hubiche T, Schuffenecker I, Boralevi F, et al. Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema. Pediatr Infect Dis J 2014; 33(4): e92-8.
[http://dx.doi.org/10.1097/INF.0000000000000120] [PMID: 24463804]
[64]
Kritikos A. Atypical hand, foot and mouth disease with eczematiform presentation in an adult patient. Int J Infect Dis 2021; 105: 397-8.
[http://dx.doi.org/10.1016/j.ijid.2021.02.075] [PMID: 33618007]
[65]
Leung AKC, Sergi CM, Lam JM, Leong KF. Gianotti–Crosti syndrome (papular acrodermatitis of childhood) in the era of a viral recrudescence and vaccine opposition. World J Pediatr 2019; 15(6): 521-7.
[http://dx.doi.org/10.1007/s12519-019-00269-9] [PMID: 31134587]
[66]
Lipe D, Affleck S. Atypical presentation of hand, foot, and mouth disease in an adult. Clin Pract Cases Emerg Med 2018; 2(2): 179-80.
[http://dx.doi.org/10.5811/cpcem.2018.3.37686] [PMID: 29849244]
[67]
Magnelli D, Zammarchi L, Antonelli A, Martelli F, Rossolini GM, Bartoloni A. Atypical hand, foot and mouth disease due to Coxsackievirus A6 in a traveler returning from Indonesia to Italy. J Travel Med 2017; 24(5)
[http://dx.doi.org/10.1093/jtm/tax029] [PMID: 28498983]
[68]
Merzel Šabović EK, Točkova O, Uršič T, Žgavec B, Dolenc-Voljč M. Atypical hand, foot, and mouth disease in an adult patient: a case report and literature review. Acta Dermatovenerol Alp Panonica Adriat 2019; 28(2): 85-8.
[http://dx.doi.org/10.15570/actaapa.2019.21] [PMID: 31233173]
[69]
Murase C, Akiyama M. Hand, foot, and mouth disease in an adult. N Engl J Med 2018; 378(14): e20.
[http://dx.doi.org/10.1056/NEJMicm1713548] [PMID: 29617579]
[70]
Murphrey M, Casselman S, Yarbrough KB. Hand, foot, and mouth disease photolocalized to sunburn. Pediatr Dermatol 2018; 35(4): e239-40.
[http://dx.doi.org/10.1111/pde.13519] [PMID: 29766552]
[71]
Nassef C, Ziemer C, Morrell DS. Hand-foot-and-mouth disease. Curr Opin Pediatr 2015; 27(4): 486-91.
[http://dx.doi.org/10.1097/MOP.0000000000000246] [PMID: 26087425]
[72]
Neri I, Dondi A, Wollenberg A, et al. Atypical forms of hand, foot, and mouth disease: A prospective study of 47 Italian children. Pediatr Dermatol 2016; 33(4): 429-37.
[http://dx.doi.org/10.1111/pde.12871] [PMID: 27292085]
[73]
No TH, Jo KM, Jung SY, et al. Coxsackievirus A6-induced hand-foot-and-mouth disease mimicking Stevens-Johnson syndrome in an immunocompetent adult. Infect Chemother 2020; 52(4): 634-40.
[http://dx.doi.org/10.3947/ic.2020.52.4.634] [PMID: 32757503]
[74]
Drago F, Ciccarese G, Broccolo F, Rebora A, Parodi A. Atypical hand, foot, and mouth disease in adults. J Am Acad Dermatol 2017; 77(2): e51-6.
[http://dx.doi.org/10.1016/j.jaad.2017.03.046] [PMID: 28711106]
[75]
Lee CJ, Chen HC. Adult hand, foot, and mouth disease. Ear Nose Throat J 2020; 99(9): NP105-6.
[http://dx.doi.org/10.1177/0145561319856569] [PMID: 31203654]
[76]
Balestri R, Bellino M, Landini L, et al. Atypical presentation of enterovirus infection in adults: outbreak of ‘hand, foot, mouth and scalp disease’ in Northern Italy. J Eur Acad Dermatol Venereol 2018; 32(2): e60-1.
[http://dx.doi.org/10.1111/jdv.14507] [PMID: 28776768]
[77]
Neri I, Chessa MA, Virdi A, Patrizi A. Hand, foot and mouth disease in adult patients. J Eur Acad Dermatol Venereol 2018; 32(2): e59-60.
[http://dx.doi.org/10.1111/jdv.14505] [PMID: 28776773]
[78]
Fölster-Holst R. Classical hand, foot and mouth disease replaced by atypical hand, foot and mouth disease. Acta Derm Venereol 2018; 98(3): 303.
[http://dx.doi.org/10.2340/00015555-2915] [PMID: 29507995]
[79]
Shiratori M, Fukai K, Hikita N, Seto T, Tsuruta D. Case of hand, foot and mouth disease with vesicular Koebner phenomenon on the ankles caused by Coxsackievirus A6 in an adult. J Dermatol 2019; 46(6): e191-2.
[http://dx.doi.org/10.1111/1346-8138.14723] [PMID: 30536870]
[80]
Teo FMS, Chu JJH. Diagnosis of human enteroviruses that cause hand, foot and mouth disease. Expert Rev Anti Infect Ther 2016; 14(5): 443-5.
[http://dx.doi.org/10.1586/14787210.2016.1173543] [PMID: 27042876]
[81]
Wang M, Ren Q, Zhang Z, et al. Rapid detection of hand, foot and mouth disease enterovirus genotypes by multiplex PCR. J Virol Methods 2018; 258: 7-12.
[http://dx.doi.org/10.1016/j.jviromet.2018.05.005] [PMID: 29758237]
[82]
Lian Z, Li H, Zhang B, et al. Neuro-magnetic resonance imaging in hand, foot, and mouth disease: Finding in 412 patients and prognostic features. J Comput Assist Tomogr 2017; 41(6): 861-7.
[http://dx.doi.org/10.1097/RCT.0000000000000627] [PMID: 28463891]
[83]
Leung AKC, Kao CP, Sauve RS. Scarring resulting from chickenpox. Pediatr Dermatol 2001; 18(5): 378-80.
[http://dx.doi.org/10.1046/j.1525-1470.2001.01975.x] [PMID: 11737678]
[84]
Leung AKC, Kellner JD. Group A β-hemolytic streptococcal pharyngitis in children. Adv Ther 2004; 21(5): 277-87.
[http://dx.doi.org/10.1007/BF02850032] [PMID: 15727397]
[85]
Leung AKC, Lam JM, Leong KF. Scabies: A neglected global disease. Curr Pediatr Rev 2020; 16(1): 33-42.
[http://dx.doi.org/10.2174/18756336OTk3jMjEcTcVY] [PMID: 31544694]
[86]
Virtuoso J, Filipe Ribeiro J, Silva ÍS, Santos S, Fernandes P, Cabral F. Pemphigus vulgaris: A rare disease in childhood. J Paediatr Child Health 2022; 58(9): 1661-3.
[http://dx.doi.org/10.1111/jpc.15866] [PMID: 34958145]
[87]
Abramovici G, Keoprasom N, Winslow CY, Tosti A. Onycholysis and subungual haemorrhages in a patient with hand, foot and mouth disease. Br J Dermatol 2014; 170(3): 748-9.
[http://dx.doi.org/10.1111/bjd.12689] [PMID: 24138462]
[88]
Clementz GC, Mancini AJ. Nail matrix arrest following hand-foot-mouth disease: a report of five children. Pediatr Dermatol 2000; 17(1): 7-11.
[http://dx.doi.org/10.1046/j.1525-1470.2000.01702.x] [PMID: 10720980]
[89]
Chiu HH, Lan CC, Wu CS, Kuo KC, Chen GS, Wei KC. Onychomadesis following hand-foot-and-mouth disease. Cutis 2016; 97(5): E20-1.
[PMID: 27274554]
[90]
Deeb M, Beach RA, Kim S. Onychomadesis following hand, foot, and mouth disease in a pregnant woman: A case report. SAGE Open Med Case Rep 2019; 7: 2050313-19845202.
[http://dx.doi.org/10.1177/2050313X19845202]
[91]
Gan X, Zhang T. Onychomadesis after hand-foot-and-mouth disease. CMAJ 2017; 189(7): E279.
[http://dx.doi.org/10.1503/cmaj.160388] [PMID: 28246241]
[92]
Hoy NY, Leung AKC, Metelitsa AI, Adams S. New concepts in median nail dystrophy, onychomycosis, and hand, foot, and mouth disease nail pathology. ISRN Dermatol 2012; 2012: 1-5.
[http://dx.doi.org/10.5402/2012/680163] [PMID: 22462009]
[93]
Irving S, Barclay-Buchanan C. Onychomadesis: A rare sequela of hand, foot, and mouth disease. J Emerg Med 2015; 49(4): e127-8.
[http://dx.doi.org/10.1016/j.jemermed.2015.04.021] [PMID: 26113378]
[94]
Kasper RS, Nobbe S, Theiler M, Weibel L. Sudden painless nail shedding. Hand-foot-and-mouth disease (HFMD). JAMA Pediatr 2015; 169(4): 405-6.
[http://dx.doi.org/10.1001/jamapediatrics.2014.3286] [PMID: 25844988]
[95]
Kuehnel NA, Thach S, Thomas DG. Onychomadesis as a late complication of hand-foot-mouth disease: A case series shedding light on nail shedding. Pediatr Emerg Care 2017; 33(11): e122-3.
[http://dx.doi.org/10.1097/PEC.0000000000001292] [PMID: 29095779]
[96]
Leung AKC, Leong KF, Lam JM. Onychomadesis in a 20-month-old child with Kawasaki disease. Case Rep Pediatr 2019; 2019: 1-3.
[http://dx.doi.org/10.1155/2019/3156736] [PMID: 30944748]
[97]
Nag SS, Dutta A, Mandal RK. Delayed cutaneous findings of hand, foot, and mouth disease. Indian Pediatr 2016; 53(1): 42-4.
[http://dx.doi.org/10.1007/s13312-016-0788-1] [PMID: 26840671]
[98]
Sechi A, Patrizi A, Leuzzi M, Chessa M, Neri I. Concomitant onychomadesis and skin rash in a 3-year-old child affected by hand, foot, and mouth disease. Indian J Dermatol 2021; 66(1): 106-8.
[http://dx.doi.org/10.4103/ijd.IJD_325_19] [PMID: 33911309]
[99]
Mortada I, Mortada R, Al Bazzal M. Onychomadesis in a 9-month-old boy with hand-foot-mouth disease. Int J Emerg Med 2017; 10(1): 26.
[http://dx.doi.org/10.1186/s12245-017-0152-9] [PMID: 28808990]
[100]
Verma S, Singal A. Nail changes in hand-foot-and-mouth disease (HFMD). Indian Dermatol Online J 2020; 12(4): 656-7.
[http://dx.doi.org/10.4103/idoj.IDOJ_271_20] [PMID: 34430491]
[101]
Apalla Z, Sotiriou E, Pikou O, et al. Onychomadesis after hand-foot-and-mouth disease outbreak in northern Greece: case series and brief review of the literature. Int J Dermatol 2015; 54(9): 1039-44.
[http://dx.doi.org/10.1111/ijd.12592] [PMID: 25772385]
[102]
Long D, Zhu S, Li C, Chen C, Du W, Wang X. Late-onset nail changes associated with hand, foot, and mouth disease: A clinical analysis of 56 cases. Pediatr Dermatol 2016; 33(4): 424-8.
[http://dx.doi.org/10.1111/pde.12878] [PMID: 27292264]
[103]
Bağcı IS, Flaig MJ, Ruzicka T, Sárdy M. Proximal onycholysis as a complication of hand, foot, and mouth disease. Int J Dermatol 2017; 56(3): e61-2.
[http://dx.doi.org/10.1111/ijd.13512] [PMID: 28083877]
[104]
Chiu HH, Wu CS, Lan CCE. Onychomadesis: A late complication of hand, foot, and mouth disease. J Emerg Med 2017; 52(2): 243-5.
[http://dx.doi.org/10.1016/j.jemermed.2016.01.034] [PMID: 27717588]
[105]
Xavier JPO, Junior JCCX. Onychomadesis secondary to hand-foot-and-mouth disease: report of two cases. An Bras Dermatol 2020; 95(2): 266-8.
[http://dx.doi.org/10.1016/j.abd.2019.06.011] [PMID: 32165023]
[106]
Yüksel S, Evrengül H, Özhan B, Yüksel G. Onychomadesis - A late complication of hand-foot-mouth disease. J Pediatr 2016; 174: 274.
[http://dx.doi.org/10.1016/j.jpeds.2016.03.073] [PMID: 27157451]
[107]
Akpolat ND, Karaca N. Nail changes secondary to hand-foot-mouth disease. Turk J Pediatr 2016; 58(3): 287-90.
[http://dx.doi.org/10.24953/turkjped.2016.03.009] [PMID: 28266194]
[108]
Jacobsen L, Zimmerman S, Lohr J. Nail findings in hand-foot-and-mouth disease. Pediatr Infect Dis J 2015; 34(4): 449-50.
[http://dx.doi.org/10.1097/INF.0000000000000574] [PMID: 25764101]
[109]
Agrawal R, Bhan K, Balaggan K, Lee RWJ, Pavesio CE, Addison PKF. Unilateral acute maculopathy associated with adult onset hand, foot and mouth disease: case report and review of literature. J Ophthalmic Inflamm Infect 2015; 5(1): 2.
[http://dx.doi.org/10.1186/s12348-015-0034-3] [PMID: 25774239]
[110]
Baldé AOM, Bakhoum M, Grimaud J. Postinfectious longitudinal extensive myelopathy after hand-foot-and-mouth disease in an immunocompetent adult. Rev Neurol (Paris) 2017; 173(1-2): 77-8.
[http://dx.doi.org/10.1016/j.neurol.2016.10.001] [PMID: 27919466]
[111]
Barrett SC, Bhat NN, Bindiganavile SH, Lee AG. Postinfectious optic neuritis after hand-foot-mouth disease. J Neuroophthalmol 2021; 41(3): e351-3.
[http://dx.doi.org/10.1097/WNO.0000000000001163] [PMID: 33417416]
[112]
Chen YF, Hu L, Xu F, Liu C, Li J. A case report of a teenager with severe hand, foot, and mouth disease with brainstem encephalitis caused by enterovirus 71. BMC Pediatr 2019; 19(1): 59.
[http://dx.doi.org/10.1186/s12887-019-1428-4] [PMID: 30760232]
[113]
Chen Z, Jiang C, Cheng X, et al. Secondary hypogonadism following hand, foot, and mouth disease in an adult: A case report and review of literature. BMC Infect Dis 2022; 22(1): 56.
[http://dx.doi.org/10.1186/s12879-022-07030-0] [PMID: 35033020]
[114]
Di Lella E, Angelini F, Campagnano S, Messineo D, Drudi FM. An unusual location of hand, foot and mouth disease. J Ultrasound 2021; 20: 1-4.
[http://dx.doi.org/10.1007/s40477-021-00558-y] [PMID: 33743167]
[115]
Duman R, Duman N, Kutluksaman B, Çetinkaya E, İnan S, İnan ÜÜ. A review of unilateral acute idiopatic maculopathy related to hand–foot–mouth disease with a representative case Int Ophthalmol 2016; 36(3): 445-52.
[http://dx.doi.org/10.1007/s10792-015-0147-6] [PMID: 26494476]
[116]
Engkakul P, Mahachoklertwattana P, Poomthavorn P. de Quervain thyroiditis in a young boy following hand–foot–mouth disease. Eur J Pediatr 2011; 170(4): 527-9.
[http://dx.doi.org/10.1007/s00431-010-1305-5] [PMID: 20886354]
[117]
Falk ZE, Malik KJ. Unilateral acute idiopathic maculopathy in a patient with hand-foot-mouth disease: A case report. Retin Cases Brief Rep 2020; 16(5): 540-2.
[http://dx.doi.org/10.1097/ICB.0000000000001046] [PMID: 32910026]
[118]
Fang Y, Lian C, Huang D, Xu L. Analysis of clinical related factors of neonatal hand-foot-mouth disease complicated with encephalitis. Front Neurol 2020; 11: 543013.
[http://dx.doi.org/10.3389/fneur.2020.543013] [PMID: 33281697]
[119]
Gonzalez G, Carr MJ, Kobayashi M, Hanaoka N, Fujimoto T. Enterovirus-associated hand-foot and mouth disease and neurological complications in Japan and the rest of the world. Int J Mol Sci 2019; 20(20): 5201.
[http://dx.doi.org/10.3390/ijms20205201] [PMID: 31635198]
[120]
Lee DS, Lee YI, Ahn JB, et al. Massive pulmonary hemorrhage in enterovirus 71-infected hand, foot, and mouth disease. Korean J Pediatr 2015; 58(3): 112-5.
[http://dx.doi.org/10.3345/kjp.2015.58.3.112] [PMID: 25861335]
[121]
Kim YJ, Kim TG. Pseudomembranous conjunctivitis with hand, foot and mouth disease in a pregnant woman: A case report. BMC Ophthalmol 2021; 21(1): 113.
[http://dx.doi.org/10.1186/s12886-021-01878-7] [PMID: 33653308]
[122]
Oska S, Bedford LM, Potts GA. Alopecia totalis following hand‐foot‐and‐mouth disease. Pediatr Dermatol 2021; 38(3): 640-2.
[http://dx.doi.org/10.1111/pde.14550] [PMID: 33650159]
[123]
Park B, Kwon H, Lee K, Kang M. Acute pancreatitis in hand, foot and mouth disease caused by Coxsackievirus A16: Case report. Korean J Pediatr 2017; 60(10): 333-6.
[http://dx.doi.org/10.3345/kjp.2017.60.10.333] [PMID: 29158768]
[124]
Rahimi R, Omar E, Tuan Soh TS, Mohd Nawi SFA, Md Noor S. A sudden paediatric death due to hand, foot and mouth disease: the importance of vigilance. Malays J Pathol 2017; 39(2): 167-70.
[PMID: 28866699]
[125]
Reich M, Cakir B, Cvetkoski S, et al. Acute unilateral maculopathy associated with adult onset of hand, foot and mouth disease: A case report. BMC Ophthalmol 2019; 19(1): 104.
[http://dx.doi.org/10.1186/s12886-019-1111-4] [PMID: 31064339]
[126]
Smith C, Scott J. Necrotising fasciitis complicating hand, foot and mouth disease. BMJ Case Rep 2019; 12(8): e228581.
[http://dx.doi.org/10.1136/bcr-2018-228581] [PMID: 31434667]
[127]
Tandon M, Gupta A, Singh P, Subathra G. Unilateral hemorrhagic maculopathy: An uncommon manifestation of hand, foot, and mouth disease. Indian J Ophthalmol 2016; 64(10): 772-4.
[http://dx.doi.org/10.4103/0301-4738.195014] [PMID: 27905343]
[128]
Talli PM, Bendo E, Pedrotti E, Pazzaglia A. Is choriocapillaris the early target in acute maculopathy secondary to hand, foot, and mouth disease? A case report. Eur J Ophthalmol 2020; 1120672120982522: 1120672120982522.
[http://dx.doi.org/10.1177/1120672120982522] [PMID: 33325253]
[129]
Taylor S, Khan M, Zaidi S, Alvi U, Fatima Y. Central serous retinopathy and hand–foot–mouth disease: Coincidence or causation? Int Med Case Rep J 2018; 11: 277-82.
[http://dx.doi.org/10.2147/IMCRJ.S181088] [PMID: 30425589]
[130]
Wong J, Langford A, Howard DL. Nonsexually transmitted genital ulcer secondary to hand, foot, and mouth disease. Obstet Gynecol 2019; 133(6): 1269-73.
[http://dx.doi.org/10.1097/AOG.0000000000003268] [PMID: 31135744]
[131]
Xu Y, Wu YF, Luo HH, Zhang DD, Wu Y, Hu P. Acute kidney injury secondary to severe hand, foot and mouth disease caused by enterovirus-A71: Hypertension is a common. J Trop Pediatr 2019; 65(5): 510-3.
[http://dx.doi.org/10.1093/tropej/fmy070] [PMID: 30462335]
[132]
Zhang YF, Deng HL, Fu J, Zhang Y, Wei JQ. Pancreatitis in hand-foot-and-mouth disease caused by enterovirus 71. World J Gastroenterol 2016; 22(6): 2149-52.
[http://dx.doi.org/10.3748/wjg.v22.i6.2149] [PMID: 26877620]
[133]
Zhou HT, Wang B, Che XY. Nephrotic syndrome in hand, foot and mouth disease caused by coxsackievirus A16: a case report. Int J Infect Dis 2014; 28: 1-2.
[http://dx.doi.org/10.1016/j.ijid.2014.04.031] [PMID: 25124453]
[134]
Zvizdic Z, Chikha A, Vranic S. Preputial balanitis xerotica obliterans shortly after hand, foot and mouth disease in a 5-year-old boy: Coincidence or consequence? Asian J Surg 2021; 44(5): 773-4.
[http://dx.doi.org/10.1016/j.asjsur.2021.02.014] [PMID: 33752984]
[135]
Chen Y, Chong CY, Cook AR, Sim NTW, Horby P, La HH. Temporal relationship between occurrences of hand, foot and mouth disease, respiratory virus detection and febrile seizures in children in tropical Singapore: A time-series analysis. Epidemiol Infect 2019; 147: e8.
[http://dx.doi.org/10.1017/S0950268818002509] [PMID: 30208978]
[136]
Leung AKC, Robson WLM. Febrile convulsions. Postgrad Med 1991; 89(5): 217-24.
[http://dx.doi.org/10.1080/00325481.1991.11700905] [PMID: 2008400]
[137]
Leung AKC, Robson WLM. Febrile Seizures. J Pediatr Health Care 2007; 21(4): 250-5.
[http://dx.doi.org/10.1016/j.pedhc.2006.10.006] [PMID: 17606162]
[138]
Leung AKC, Hon KL, Leung TNH. Febrile seizures: an overview. Drugs Context 2018; 7: 212536.
[http://dx.doi.org/10.7573/dic.212536] [PMID: 30038660]
[139]
Lim ZQ, Ng QY, Ng JWQ, Mahendran V, Alonso S. Recent progress and challenges in drug development to fight hand, foot and mouth disease. Expert Opin Drug Discov 2020; 15(3): 359-71.
[http://dx.doi.org/10.1080/17460441.2019.1659241] [PMID: 31470744]
[140]
Nhan LNT, Turner HC, Khanh TH, et al. Economic burden attributed to children presenting to hospitals with hand, foot, and mouth disease in Vietnam. Open Forum Infect Dis 2019; 6(7): ofz284.
[http://dx.doi.org/10.1093/ofid/ofz284] [PMID: 31363772]
[141]
Zheng Y, Jit M, Wu JT, et al. Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China. PLoS One 2017; 12(9): e0184266.
[http://dx.doi.org/10.1371/journal.pone.0184266] [PMID: 28934232]
[142]
Huang J, Liao Q, Ooi MH, et al. Epidemiology of recurrent hand, foot and mouth disease, China, 2008-2015. Emerg Infect Dis 2018; 24(3): 432-42.
[http://dx.doi.org/10.3201/eid2403.171303] [PMID: 29460747]
[143]
Chew SP, Chong SL, Barbier S, Matthew A, Lee JH, Chan YH. Risk factors for severe hand foot mouth disease in Singapore: A case control study. BMC Infect Dis 2015; 15(1): 486.
[http://dx.doi.org/10.1186/s12879-015-1195-2] [PMID: 26520791]
[144]
Fang Y, Wang S, Zhang L, et al. Risk factors of severe hand, foot and mouth disease: A meta-analysis. Scand J Infect Dis 2014; 46(7): 515-22.
[http://dx.doi.org/10.3109/00365548.2014.907929] [PMID: 24832848]
[145]
Li P, Huang Y, Zhu D, Yang S, Hu D. Risk factors for severe hand-foot-mouth disease in China: A systematic review and meta-analysis. Front Pediatr 2021; 9: 716039.
[http://dx.doi.org/10.3389/fped.2021.716039] [PMID: 34858899]
[146]
Liu C, Wang K, Lin N, Cai J, Cui B, Wu B. Risk factors of severe hand, foot and mouth disease in Shantou, China: A case-control study. J Infect Dev Ctries 2018; 12(5): 359-64.
[http://dx.doi.org/10.3855/jidc.9845] [PMID: 31865299]
[147]
Ni XF, Li X, Xu C, et al. Risk factors for death from hand–foot–mouth disease: a meta-analysis. Epidemiol Infect 2020; 148: e44.
[http://dx.doi.org/10.1017/S0950268819002279] [PMID: 32102711]
[148]
Owatanapanich S, Wutthanarungsan R, Jaksupa W, Thisyakorn U. Risk factors for severe hand, foot, and mouth disease. Southeast Asian J Trop Med Public Health 2015; 46(3): 449-59.
[PMID: 26521518]
[149]
Peng L, Luo R, Jiang Z. Risk factors for neurogenic pulmonary edema in patients with severe hand, foot, and mouth disease: A meta-analysis. Int J Infect Dis 2017; 65: 37-43.
[http://dx.doi.org/10.1016/j.ijid.2017.09.020] [PMID: 28970089]
[150]
Song C, Yibing C, Guo Y, Jin Z, Cui Y, Gu X. Risk factors of severe hand, foot and mouth disease complicated with cardiopulmonary collapse. Infect Dis (Lond) 2015; 47(7): 453-7.
[http://dx.doi.org/10.3109/23744235.2015.1015051] [PMID: 25712793]
[151]
Song C, Li Y, Zhou Y, et al. Enterovirus genomic load and disease severity among children hospitalised with hand, foot and mouth disease. EBioMedicine 2020; 62: 103078.
[http://dx.doi.org/10.1016/j.ebiom.2020.103078] [PMID: 33161231]
[152]
Sun BJ, Chen HJ, Chen Y, An XD, Zhou BS. The risk factors of acquiring severe hand, foot, and mouth disease: A meta-analysis. Can J Infect Dis Med Microbiol 2018; 2018: 1-12.
[http://dx.doi.org/10.1155/2018/2751457] [PMID: 30046361]
[153]
Tyring SK. Hand foot and mouth disease: Enteroviral load and disease severity. EBioMedicine 2020; 62: 103115.
[http://dx.doi.org/10.1016/j.ebiom.2020.103115] [PMID: 33181466]
[154]
Jones E, Pillay TD, Liu F, et al. Outcomes following severe hand foot and mouth disease: A systematic review and meta-analysis. Eur J Paediatr Neurol 2018; 22(5): 763-73.
[http://dx.doi.org/10.1016/j.ejpn.2018.04.007] [PMID: 29778429]
[155]
Liang L, Cheng Y, Li Y, et al. Long-term neurodevelopment outcomes of hand, foot and mouth disease inpatients infected with EV-A71 or CV-A16, a retrospective cohort study. Emerg Microbes Infect 2021; 10(1): 545-54.
[http://dx.doi.org/10.1080/22221751.2021.1901612] [PMID: 33691598]
[156]
Shah J, Sijun L, Hui Z, Zeb F, Haq IU, Ullah A. Neurological complications of hand, foot and mouth disease in children: A review. J Ayub Med Coll Abbottabad 2020; 32(4): 562-9.
[PMID: 33225664]
[157]
Hess GP, Walson PD. Seizures secondary to oral viscous lidocaine. Ann Emerg Med 1988; 17(7): 725-7.
[http://dx.doi.org/10.1016/S0196-0644(88)80623-1] [PMID: 3382075]
[158]
Hopper SM, McCarthy M, Tancharoen C, Lee KJ, Davidson A, Babl FE. Topical lidocaine to improve oral intake in children with painful infectious mouth ulcers: A blinded, randomized, placebo-controlled trial. Ann Emerg Med 2014; 63(3): 292-9.
[http://dx.doi.org/10.1016/j.annemergmed.2013.08.022] [PMID: 24210368]
[159]
Wang SM, Lei HY, Huang MC, et al. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol 2006; 37(1): 47-52.
[http://dx.doi.org/10.1016/j.jcv.2006.05.009] [PMID: 16861032]
[160]
Wang SM, Lei HY, Liu CC. Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis. Clin Dev Immunol 2012; 2012: 1-8.
[http://dx.doi.org/10.1155/2012/876241] [PMID: 22956971]
[161]
Jiao W, Tan SR, Huang YF, et al. The effectiveness of different doses of intravenous immunoglobulin on severe hand, foot and mouth disease: A meta-analysis. Med Princ Pract 2019; 28(3): 256-63.
[http://dx.doi.org/10.1159/000496926] [PMID: 30646003]
[162]
Palabrica FRR, Kwong SL, Padua FR. Adverse events of intravenous immunoglobulin infusions: A ten-year retrospective study. Asia Pac Allergy 2013; 3(4): 249-56.
[http://dx.doi.org/10.5415/apallergy.2013.3.4.249] [PMID: 24260730]
[163]
Stiehm ER. Adverse effects of human immunoglobulin therapy. Transfus Med Rev 2013; 27(3): 171-8.
[http://dx.doi.org/10.1016/j.tmrv.2013.05.004] [PMID: 23835249]
[164]
Koh WM, Bogich T, Siegel K, et al. The epidemiology of hand, foot and mouth disease in Asia: A systematic review and analysis. Pediatr Infect Dis J 2016; 35(10): e285-300.
[http://dx.doi.org/10.1097/INF.0000000000001242] [PMID: 27273688]
[165]
Leung AK, Sauve RS. Breast is best for babies. J Natl Med Assoc 2005; 97(7): 1010-9.
[PMID: 16080672]
[166]
Li Y, Deng H, Li M, et al. Prolonged breastfeeding is associated with lower risk of severe hand, foot and mouth disease in Chinese children. Pediatr Infect Dis J 2016; 35(3): 353-5.
[http://dx.doi.org/10.1097/INF.0000000000001001] [PMID: 26650113]
[167]
Li Y, Xiong T, Meng Y, et al. Risk factors for severe hand, foot, and mouth disease infected with Coxsackievirus A6: A hospital‐based case‐control study. J Med Virol 2020; 92(12): 3144-50.
[http://dx.doi.org/10.1002/jmv.26343] [PMID: 32706451]
[168]
Lin H, Sun L, Lin J, et al. Protective effect of exclusive breastfeeding against hand, foot and mouth disease. BMC Infect Dis 2014; 14(1): 645.
[http://dx.doi.org/10.1186/s12879-014-0645-6] [PMID: 25471294]
[169]
Wang Z, Liu T, Li J, Gu Q. Risk factors for hand, foot, and mouth disease caused by coxsackievirus A6 in children under 6 years of age in Tianjin, China: A case-control study. Jpn J Infect Dis 2021; 74(5): 437-42.
[http://dx.doi.org/10.7883/yoken.JJID.2020.983] [PMID: 33518630]
[170]
Zhang D, Li Z, Zhang W, et al. Hand-washing: The main strategy for avoiding hand, foot and mouth disease. Int J Environ Res Public Health 2016; 13(6): 610.
[http://dx.doi.org/10.3390/ijerph13060610] [PMID: 27322307]
[171]
Modlin JF. Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention.UpToDate.
[172]
Geng Y, Zhang L. Impact of non-pharmaceutical interventions during COVID-19 pandemic on pertussis, scarlet fever and handfoot-mouth disease in China. J Infect 2021; S0163-4453(21): 00645-9.
[http://dx.doi.org/10.1016/j.jinf.2021.12.023]
[173]
Zhao Z, Zheng C, Qi H, et al. Impact of the coronavirus disease 2019 interventions on the incidence of hand, foot, and mouth disease in mainland China. Lancet Regional Health - Western Pacific 2022; 20: 100362.
[http://dx.doi.org/10.1016/j.lanwpc.2021.100362] [PMID: 35005671]
[174]
Fang CY, Liu CC. Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies. Expert Opin Drug Discov 2022; 17(1): 27-39.
[http://dx.doi.org/10.1080/17460441.2021.1965987] [PMID: 34382876]
[175]
Jiang L, Wang J, Zhang C, et al. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China. Vaccine 2020; 38(7): 1804-9.
[http://dx.doi.org/10.1016/j.vaccine.2019.12.025] [PMID: 31892446]
[176]
Du Z, Huang Y, Bloom MS, et al. Assessing the vaccine effectiveness for hand, foot, and mouth disease in Guangzhou, China: A time-series analysis. Hum Vaccin Immunother 2021; 17(1): 217-23.
[http://dx.doi.org/10.1080/21645515.2020.1763076] [PMID: 32530733]
[177]
He X, Zhang M, Zhao C, Zheng P, Zhang X, Xu J. From monovalent to multivalent vaccines, the exploration for potential preventive strategies against hand, foot, and mouth disease (HFMD). Virol Sin 2021; 36(2): 167-75.
[http://dx.doi.org/10.1007/s12250-020-00294-3] [PMID: 32997323]
[178]
He F, Rui J, Deng Z, et al. Surveillance, epidemiology and impact of EV-A71 vaccination on hand, foot, and mouth disease in Nanchang, China, 2010-2019. Front Microbiol 2022; 12: 811553.
[http://dx.doi.org/10.3389/fmicb.2021.811553] [PMID: 35069515]
[179]
Hong J, Liu F, Qi H, et al. Changing epidemiology of hand, foot, and mouth disease in China, 2013−2019: A population-based study. Lancet Regional Health - Western Pacific 2022; 20: 100370.
[http://dx.doi.org/10.1016/j.lanwpc.2021.100370] [PMID: 35036978]
[180]
Li J, Yin X, Lin A, et al. EV71 vaccination impact on the incidence of encephalitis in patients with hand, foot and mouth disease. Hum Vaccin Immunother 2021; 17(7): 2097-100.
[http://dx.doi.org/10.1080/21645515.2020.1851129] [PMID: 33522390]
[181]
Liu D, Leung K, Jit M, et al. Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease. Clin Microbiol Infect 2020; 26(3): 373-80.
[http://dx.doi.org/10.1016/j.cmi.2019.06.029] [PMID: 31279839]
[182]
Wang J, Jiang L, Zhang C, He W, Tan Y, Ning C. The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine. Vaccine 2021; 39(25): 3319-23.
[http://dx.doi.org/10.1016/j.vaccine.2021.05.009] [PMID: 33994239]
[183]
Yu H, Cowling BJ. Remaining challenges for prevention and control of hand, foot, and mouth disease. Lancet Child Adolesc Health 2019; 3(6): 373-4.
[http://dx.doi.org/10.1016/S2352-4642(19)30065-3] [PMID: 30885695]
[184]
Pan S, Qian J, Gong X, Zhou Y. Effects of ribavirin aerosol on viral exclusion of patients with hand-foot-mouth disease. Zhonghua Yi Xue Za Zhi 2014; 94(20): 1563-6.
[PMID: 25146745]
[185]
Tian H, Yang QZ, Liang J, Dong SY, Liu ZJ, Wang LX. Clinical features and management outcomes of severe hand, foot and mouth disease. Med Princ Pract 2012; 21(4): 355-9.
[http://dx.doi.org/10.1159/000334619] [PMID: 22188681]
[186]
Zhang HP, Wang L, Qian JH, et al. Efficacy and safety of ribavirin aerosol in children with hand-foot-mouth disease. Zhongguo Dang Dai Er Ke Za Zhi 2014; 16(3): 272-6.
[PMID: 24661520]
[187]
Ren P, Zou G, Bailly B, et al. The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo. Emerg Microbes Infect 2014; 3(1): 1-9.
[http://dx.doi.org/10.1038/emi.2014.60] [PMID: 26038755]
[188]
Wang Y, Qing J, Sun Y, Rao Z. Suramin inhibits EV71 infection. Antiviral Res 2014; 103: 1-6.
[http://dx.doi.org/10.1016/j.antiviral.2013.12.008] [PMID: 24374150]
[189]
Thibaut HJ, Leyssen P, Puerstinger G, Muigg A, Neyts J, De Palma AM. Towards the design of combination therapy for the treatment of enterovirus infections. Antiviral Res 2011; 90(3): 213-7.
[http://dx.doi.org/10.1016/j.antiviral.2011.03.187] [PMID: 21466823]
[190]
Wang Y, Li G, Yuan S, et al. In vitro assessment of combinations of enterovirus inhibitors against enterovirus 71. Antimicrob Agents Chemother 2016; 60(9): 5357-67.
[http://dx.doi.org/10.1128/AAC.01073-16] [PMID: 27353263]
[191]
Cao Y, Lei E, Li L, et al. Antiviral activity of Mulberroside C against enterovirus A71 in vitro and in vivo. Eur J Pharmacol 2021; 906: 174204.
[http://dx.doi.org/10.1016/j.ejphar.2021.174204] [PMID: 34051220]
[192]
Tseng KC, Hsu BY, Ling P, Lu WW, Lin CW, Kung SH. Antidepressant sertraline is a broad-spectrum inhibitor of enteroviruses targeting viral entry through neutralization of endolysosomal acidification. Viruses 2022; 14(1): 109.
[http://dx.doi.org/10.3390/v14010109] [PMID: 35062313]
[193]
Xu Z, Tang Q, Xu T, et al. Discovery of aminothiazole derivatives as novel human enterovirus A71 capsid protein inhibitors. Bioorg Chem 2022; 122: 105683.
[http://dx.doi.org/10.1016/j.bioorg.2022.105683] [PMID: 35278779]
[194]
Batts AF, Jalalat SZ, Hunter-Ellul L, Wilkerson MG. Exacerbation of bullous pemphigoid after hand, foot, and mouth disease treated with rituximab. JAAD Case Rep 2016; 2(1): 7-9.
[http://dx.doi.org/10.1016/j.jdcr.2015.11.006] [PMID: 27051813]
[195]
Jie C, Li-Po H, Yu Z, Yuan-da Z. Effectiveness of gamma globulin combined with methylprednisolone sodium succinate in severe hand foot mouth disease-Baoding Children’s Hospital, China. J Pak Med Assoc 2020; 70(10): 1679-83.
[http://dx.doi.org/10.5455/JPMA.9386] [PMID: 33159732]
[196]
Huang X, Zhang X, Wang F, et al. Clinical efficacy of therapy with recombinant human interferon α1b in hand, foot, and mouth disease with enterovirus 71 infection. PLoS One 2016; 11(2): e0148907.
[http://dx.doi.org/10.1371/journal.pone.0148907] [PMID: 26882102]
[197]
Lin H, Huang L, Zhou J, et al. Efficacy and safety of interferon-α2b spray in the treatment of hand, foot, and mouth disease: A multicenter, randomized, double-blind trial. Arch Virol 2016; 161(11): 3073-80.
[http://dx.doi.org/10.1007/s00705-016-3012-7] [PMID: 27518403]
[198]
Yi L, He Y, Chen Y, Kung HF, He ML. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir Ther 2011; 16(1): 51-8.
[http://dx.doi.org/10.3851/IMP1720] [PMID: 21311108]
[199]
Phan QT, Phung LK, Truong KH, et al. Assessing the efficacy and safety of magnesium sulfate for management of autonomic nervous system dysregulation in Vietnamese children with severe hand foot and mouth disease. BMC Infect Dis 2019; 19(1): 737.
[http://dx.doi.org/10.1186/s12879-019-4356-x] [PMID: 31438878]
[200]
Qui PT, Khanh TH, Trieu HT, et al. Intravenous magnesium sulfate for the management of severe hand, foot, and mouth disease with autonomic nervous system dysregulation in Vietnamese children: Study protocol for a randomized controlled trial. Trials 2016; 17(1): 98.
[http://dx.doi.org/10.1186/s13063-016-1215-6] [PMID: 26896318]
[201]
Li W, Zhu Y, Li Y, et al. The gut microbiota of hand, foot and mouth disease patients demonstrates down‐regulated butyrate‐producing bacteria and up‐regulated inflammation‐inducing bacteria. Acta Paediatr 2019; 108(6): 1133-9.
[http://dx.doi.org/10.1111/apa.14644] [PMID: 30427066]
[202]
Shen C, Xu Y, Ji J, et al. Intestinal microbiota has important effect on severity of hand foot and mouth disease in children. BMC Infect Dis 2021; 21(1): 1062.
[http://dx.doi.org/10.1186/s12879-021-06748-7] [PMID: 34645414]
[203]
Guo X, Lan Z, Wen Y, et al. Synbiotics supplements lower the risk of hand, foot, and mouth disease in children, potentially by providing resistance to gut microbiota dysbiosis. Front Cell Infect Microbiol 2021; 11: 729756.
[http://dx.doi.org/10.3389/fcimb.2021.729756] [PMID: 34660342]
[204]
Zhu F, Jiang Z, Li HW. Intestinal probiotics in relieving clinical symptoms of severe hand, foot, and mouth disease and potential mechanism analysis. Eur Rev Med Pharmacol Sci 2017; 21(18): 4214-8.
[PMID: 29028076]
[205]
Zhang H, Zhang L, Xie J, Wen W, Wei L, Nie B. Probiotics supplement in children with severe hand, foot, and mouth disease. Medicine 2019; 98(45): e17939.
[http://dx.doi.org/10.1097/MD.0000000000017939] [PMID: 31702682]
[206]
Ji P, Chen C, Hu Y, et al. Antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease. Biol Pharm Bull 2015; 38(1): 1-6.
[http://dx.doi.org/10.1248/bpb.b14-00357] [PMID: 25744451]
[207]
Ji H, Fan H, Ai J, et al. Neurocognitive deficits and sequelae following severe hand, foot, and mouth disease from 2009 to 2017, in JiangSu Province, China: A long-term follow-up study. Int J Infect Dis 2022; 115: 245-55.
[http://dx.doi.org/10.1016/j.ijid.2021.11.026] [PMID: 34910955]
[208]
Lalani S, Masomian M, Poh CL. Functional insights into silymarin as an antiviral agent against enterovirus A71 (EV-A71). Int J Mol Sci 2021; 22(16): 8757.
[http://dx.doi.org/10.3390/ijms22168757] [PMID: 34445463]
[209]
Tan JK, Chen R, Lee RCH, et al. Discovery of novel andrographolide derivatives as antiviral inhibitors against human enterovirus A71. Pharmaceuticals (Basel) 2022; 15(2): 115.
[http://dx.doi.org/10.3390/ph15020115] [PMID: 35215228]
[210]
Tang J, Zhang G, Xing J, Yu Y, Han T. Network meta-analysis of heat-clearing and detoxifying oral liquid of Chinese medicines in treatment of children’s hand-foot-mouth disease. Medicine (Baltimore) 2022; 101(5): e28778.
[http://dx.doi.org/10.1097/MD.0000000000028778] [PMID: 35119042]
[211]
Wen T, Xu W, Liang L, et al. Clinical efficacy of andrographolide sulfonate in the treatment of severe hand, foot, and mouth disease (HFMD) is dependent upon inhibition of neutrophil activation. Phytother Res 2015; 29(8): 1161-7.
[http://dx.doi.org/10.1002/ptr.5361] [PMID: 25960284]
[212]
Zhang D, Chen J, Ba-Thein W. Hand-foot-mouth disease and use of steroids, intravenous immunoglobulin, and traditional Chinese herbs in a tertiary hospital in Shantou, China. BMC Complement Altern Med 2018; 18(1): 190.
[http://dx.doi.org/10.1186/s12906-018-2259-9] [PMID: 29925360]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy